MedPage Today on MSN
Color Blindness and Bladder Cancer: A Bad Combination for Survival?
A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder ...
HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for colorectal cancer (CRC) incidence compared with aspirin, according to a study presented ...
Mycophenolate mofetil treatment in patients with limited cutaneous systemic sclerosis is linked to a reduced need for escalation of vasoactive or vasodilator therapies for vascular complications.
Nutritional support enhances treatment continuity in malnourished patients with advanced gastric cancer and independently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results